PEAK6 Group’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6 Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$3.82M	Buy	+34,807	New	+$3.72M	0.02%	923
2018 Q1	–	Sell	-128,106	Closed	-$14.2M	–	4580
2017 Q4	$13.7M	Buy	128,106 +45,360	+55%	+$4.85M	0.06%	350
2017 Q3	$9.2M	Buy	82,746 +72,750	+728%	+$7.78M	0.05%	459
2017 Q2	$1.03M	Sell	9,996 -43,758	-81%	-$4.31M	0.01%	1896
2017 Q1	$5.25M	Sell	53,754 -83,667	-61%	-$8.01M	0.04%	551
2016 Q4	$12.2M	Buy	137,421 +49,635	+57%	+$4.52M	0.09%	283
2016 Q3	$8.47M	Buy	87,786 +67,242	+327%	+$6.4M	0.06%	422
2016 Q2	$1.76M	Sell	20,544 -87,951	-81%	-$7.89M	0.01%	1334
2016 Q1	$9.43M	Buy	108,495 +68,235	+169%	+$6.1M	0.08%	342
2015 Q4	$4.54M	Sell	40,260 -64,746	-62%	-$7.03M	0.03%	792
2015 Q3	$10.6M	Buy	105,006 +64,857	+162%	+$7.78M	0.06%	442
2015 Q2	$4.94M	Buy	+40,149	New	+$4.81M	0.03%	848
2015 Q1	–	Sell	-24,582	Closed	-$2.71M	–	4943
2014 Q4	$2.49M	Buy	+24,582	New	+$2.39M	0.02%	1126
2014 Q3	–	Sell	-28,377	Closed	-$2.43M	–	4881
2014 Q2	$2.43M	Buy	+28,377	New	+$2.24M	0.02%	948

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PEAK6 Group's IBB Position: Q2 2018 in Review

PEAK6 Group opened a new position in iShares Biotechnology ETF (IBB) in Q2 2018: 34,807 shares worth $3.82M. The stake represents 0.02% of the portfolio and ranks #923 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in IBB as recently as Q4 2017.

PEAK6 Group first reported a position in IBB in Q2 2014 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2017. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

PEAK6 Group held 34,807 shares of iShares Biotechnology ETF worth $3.82M as of Q2 2018.
iShares Biotechnology ETF was a new PEAK6 Group position in Q2 2018.
iShares Biotechnology ETF made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #923 holding.
PEAK6 Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 14 quarters since.
PEAK6 Group's iShares Biotechnology ETF position peaked at $13.7M in Q4 2017.
609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.